Barnes & Noble (BNED) Flexes $1.57B Revenue Increase in its FY24 Results
Barnes & Noble Education, Inc. (BNED), a top education solutions…
FDA Approves Iterum (ITRM)’s ORLYNVAH™ for Resistant UTIs
Iterum Therapeutics plc (ITRM) has received U.S. FDA approval for…
Checkpoint’s Cosibelimab Shows Promising Results for Advanced Skin Cancer
Checkpoint Therapeutics, Inc. (CKPT), a clinical-stage immunotherapy and oncology company,…
Euroseas (ESEA) Q2 2024 Earnings Surge with 23% Revenue Growth
Euroseas Ltd. (ESEA), a prominent container shipping operator, delivered significant…
LexinFintech’s Q2 2024 Revenue Up 19.1% on Strong Credit Services
LexinFintech Holdings Ltd. (LX), a leading personal finance service enabler…
Fidelity D & D (FDBC) in Q3 2024: $5M Income, Strategic Growth
Fidelity D & D Bancorp, Inc. (FDBC), parent to The…
Fate Therapeutics (FATE) Reports Strong Q2 2024 Results
Fate Therapeutics, Inc. (FATE), a leader in iPSC-derived cellular immunotherapies,…
Innodata (INOD) Posts 54% Q2 Revenue Growth, Driven by DDS Surge
Innodata Inc. (INOD) reported impressive growth for Q2 2024, with…
Outbrain (OB) Reports $248.2M Revenue in Q4 2023
Outbrain Inc. (OB), a leader in technology for the Open…
E.W. Scripps (SSP) Hits $646M in Q3 Revenue, Fueled by Political Ads
The E.W. Scripps Company (SSP) achieved a remarkable milestone in…
